Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression - Wikidata - awgldk - TriplyDB

Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression

Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression

http://www.wikidata.org/entity/Q28305905

about

The potential role of podoplanin in tumour invasion Podoplanin - a small glycoprotein with many faces Increased Oxidative Stress as a Selective Anticancer Therapy EGFR Amplification and Glioblastoma Stem-Like Cells Establishment and Characterization of a Tumor Stem Cell-Based Glioblastoma Invasion Model The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma Podoplanin: emerging functions in development, the immune system, and cancer Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells.Cell growth inhibition and apoptotic effects of a specific anti-RTFscFv antibody on prostate cancer, but not glioblastoma, cells Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation A cancer-specific monoclonal antibody recognizes the aberrantly glycosylated podoplanin.Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin.Identification of valid endogenous control genes for determining gene expression in human glioma.Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas STAT3 silencing inhibits glioma single cell infiltration and tumor growth Prognostic value of glioma cancer stem cell isolation in survival of primary glioblastoma patients.Transcriptional network analysis reveals that AT1 and AT2 angiotensin II receptors are both involved in the regulation of genes essential for glioma progression.Radiotherapy followed by aurora kinase inhibition targets tumor-propagating cells in human glioblastoma LpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-Glycan on Thr52 of Platelet Aggregation-Stimulating Domain of Human Podoplanin.An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery.Morphological study of tooth development in podoplanin-deficient mice.Phosphorylated mTOR expression correlates with podoplanin expression and high tumor grade in esophageal squamous cell carcinoma.Engineering of mucin-type human glycoproteins in yeast cells.The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity.Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma Platelet aggregation in the formation of tumor metastasis.Podoplanin-mediated TGF-β-induced epithelial-mesenchymal transition and its correlation with bHLH transcription factor DEC in TE-11 cells.Non-invasive neural stem cells become invasive in vitro by combined FGF2 and BMP4 signaling High-grade glioma before and after treatment with radiation and Avastin: initial observations.Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors.Distribution of podoplanin-expressing cells in the mouse nervous systems.A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis.Development and characterization of anti-glycopeptide monoclonal antibodies against human podoplanin, using glycan-deficient cell lines generated by CRISPR/Cas9 and TALEN.Expressions of ABCG2, CD133, and podoplanin in salivary adenoid cystic carcinoma.Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation.Novel platelet activation receptor CLEC-2: from discovery to prospects.What is the clinical value of cancer stem cell markers in gliomas?

P2860

Q24653540-EAAC3EA5-BE6A-45E1-AF84-8A907C4BC68D Q26749146-D293F172-8D5B-41CF-9329-A0E5B443BE8E Q26798210-CD59836D-9BD8-4AF2-AECC-559886CD55A8 Q26853549-0C9DA640-D989-475C-9660-4E11B9F8AF70 Q27333230-47BFF6A2-CEF2-469B-AA6A-14F7A09A1DFC Q28221740-3DFD2F53-4095-46DB-9610-89291A24FF61 Q28261810-74D8AC4C-BA97-4F33-8FB9-521450B05A7D Q28275310-4A88CB60-0F2A-4DDC-9A38-0DAB7EE7F799 Q28279046-65A3B753-113C-4F61-9D70-A83847C9C63C Q28600973-C7ABC179-D9C9-4966-9BC1-670F52ECCC6D Q30032296-16910924-86CB-46E9-BB4D-17C22085E020 Q33589310-3CEAE902-CD4E-4863-B60A-D32B2D06870B Q33826371-3F6101CB-AB71-4B1E-B89F-2ACA04F72321 Q33985502-5DB2D48F-3F55-4F33-A748-A4FDB582A6F0 Q34033409-F1F770D2-E31B-45A8-B972-DDBBA06F26D1 Q34132923-D6A71896-65E9-4190-A629-13EED9AB8DD2 Q34160649-1D28CB95-C40A-453B-BACF-2A92C66BB6B2 Q34619737-59F50137-853F-4DA2-B48B-6D53DC12C855 Q34785641-2B16ABB9-05F6-4623-BE76-B4F2B89B3781 Q35388346-061D6457-D800-4946-9A2A-7C51D84AF80E Q35529926-0D8BBAA8-6BDA-431D-B0AD-F4E353398E97 Q35975006-5D27B7BC-C35A-40FB-9137-6755B8CB0447 Q36119941-C689DD0B-BC2C-460C-9F05-D1B05F07C346 Q36286148-7B94F876-46A2-4C3F-9B9C-4C5BFC6C6443 Q36375220-863D2998-5411-4964-8312-72C9863917A4 Q36491059-728A59B2-5F4C-4916-98A8-9008232028FA Q36546538-9743B4CF-8F8A-4EED-B5FF-B6378833A0E4 Q36787626-97D43D15-3975-44D4-A9F7-899B7C33A6B2 Q36880332-27172347-A097-47F9-BC58-639DA9D61B1C Q36891662-A7B9F49D-EBEF-4C14-AA10-F0D5F900CA55 Q37096486-57EB56E7-C6AB-4632-B5E8-54B28C01DDFE Q37152024-DD3DCBD0-0220-44F6-9B3C-D9404FCC32D6 Q37259430-715A5184-C919-4292-A3DD-6955CE977B40 Q37593917-5E0700F7-57EE-45BB-AB61-926B95E9DA64 Q37631100-95EB96EC-854C-4C0E-9377-DE7DE8837CB7 Q37648097-CCF81320-A468-46D1-ADDB-BB28E266508E Q37720504-8C41B1C2-5D8F-4A57-8466-58BF2CBF1C85 Q37892739-BBC08563-797F-4B62-B733-4AE6F77552AA Q37903930-C4224937-167F-4877-BE11-479E87133145 Q38081776-DA3D9220-10F3-4B68-A07E-9C02EF93E255

P2860

Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression

http://www.wikidata.org/entity/Q28305905

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Increased expression of podopl ...... arker of malignant progression

@ast

Increased expression of podopl ...... arker of malignant progression

@en

Increased expression of podopl ...... arker of malignant progression

@nl

type

label

Increased expression of podopl ...... arker of malignant progression

@ast

Increased expression of podopl ...... arker of malignant progression

@en

Increased expression of podopl ...... arker of malignant progression

@nl

prefLabel

Increased expression of podopl ...... arker of malignant progression

@ast

Increased expression of podopl ...... arker of malignant progression

@en

Increased expression of podopl ...... arker of malignant progression

@nl

P1433

Q28305905-F3950A05-7194-41A8-ADBA-CDD7D23547E5

P1476

Q28305905-1CF6E412-C338-498C-A935-E4A70D3A6F51

P2093

Q28305905-09CC2CF2-304F-409A-AD37-7F3A7BD00597

Q28305905-21F70FDB-264F-4C49-AB11-A0651935F77D

Q28305905-547D68F0-49F9-4611-8443-C4F2410DAE1E

Q28305905-B5383D7C-B3DA-40F0-8AF5-578E0520D889

Q28305905-F3B4D9D3-BE42-47AA-B9B1-7157F0F32199

P2860

Q28305905-053F9121-DB3C-4634-9216-DB4B33DAF8DD

Q28305905-3C041949-EA22-4379-A484-32FADD4DDFA2

Q28305905-EE143D48-51F2-4F7D-820C-06FDFEAAC758

P2888

Q28305905-268D7323-9DD2-4C8E-9888-C7C2CA555610

P304

Q28305905-827DC172-5559-4D83-9024-5D048E441BD0

P31

Q28305905-7E0F0549-2824-4BEB-99FB-75958D7F5A5D

P3181

Q28305905-907CA5F8-786F-4CBA-B0A9-63FBD43C7212

P356

Q28305905-527590B9-3794-4F36-B343-189BAD690FAD

P407

Q28305905-C80BB5F8-F62D-4FF6-B0B8-453F59F8AD57

P433

Q28305905-73BA2824-5785-4F28-AAED-B1D08599B60B

P478

Q28305905-3CEFF184-E8C9-4C40-A79F-4044EA3CF71C

P50

Q28305905-23BEA4A6-7567-4B35-8612-32D0BEBCF5EE

P577

Q28305905-DF18340D-0F5B-45A8-A2FF-E39863AED6F8

P5875

Q28305905-07E4CA64-4D5E-4107-8B1E-3E4149D4CE88

P6179

Q28305905-63F91D0F-A7A2-4161-B2B4-5BF57EA09BB2

P698

Q28305905-7AFEB34C-D946-4CA4-AA22-A75725FC96C1

P3181

P356

S00401-006-0063-Y

P1433

Acta Neuropathologica

P1476

Increased expression of podopl ...... arker of malignant progression

@en

P2093

Kazuhiko Mishima

http://www.w3.org/2001/XMLSchema#string

Masao Matsutani

http://www.w3.org/2001/XMLSchema#string

Mika Kato Kaneko

http://www.w3.org/2001/XMLSchema#string

Ryo Nishikawa

http://www.w3.org/2001/XMLSchema#string

Takanori Hirose

http://www.w3.org/2001/XMLSchema#string

P2860

Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors

Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.

Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.

P2888

s00401-006-0063-y

P304

483-488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4422258

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S00401-006-0063-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7184240

http://www.w3.org/2001/XMLSchema#string

P6179

1027218848

http://www.w3.org/2001/XMLSchema#string

P698

16596424

http://www.w3.org/2001/XMLSchema#string